XML 76 R48.htm IDEA: XBRL DOCUMENT
v3.22.1

Financial Instruments (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Financial Instruments [Abstract] |
Schedule of financial assets | The carrying amounts of the Company’s financial instruments by category were as follows:
|  | 2021
Asset (liability) |  | Financial assets at amortized cost |  | Fair value through profit or loss |  | Derivatives used for hedging |  | Financial liabilities at amortized cost |  | Total
Cash and cash equivalents |  | $ | 744 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 744 |
Accounts receivable |  | 3,111 |  |  | — |  |  | — |  |  | — |  |  | 3,111 |
Investments |  | — |  |  | 309 |  |  | — |  |  | — |  |  | 309 |
Other long-term assets |  | — |  |  | — |  |  | 140 |  |  | — |  |  | 140 |
Accounts payable |  | — |  |  | — |  |  | — |  |  | (803) |  |  | (803) |
Accrued liabilities |  | — |  |  | — |  |  | — |  |  | (3,064) |  |  | (3,064) |
Other long-term liabilities (1) |  | — |  |  | (64) |  |  | (21) |  |  | (1,632) |  |  | (1,717) |
Long-term debt (2) |  | — |  |  | — |  |  | — |  |  | (14,694) |  |  | (14,694) |
|  | $ | 3,855 |  |  | $ | 245 |  |  | $ | 119 |  |  | $ | (20,193) |  |  | $ | (15,974) |
|  | 2020
Asset (liability) |  | Financial assets at amortized cost |  | Fair value through profit or loss |  | Derivatives used for hedging |  | Financial liabilities at amortized cost |  | Total
Cash and cash equivalents |  | $ | 184 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 184 |
Accounts receivable |  | 2,190 |  |  | — |  |  | — |  |  | — |  |  | 2,190 |
Investments |  | — |  |  | 305 |  |  | — |  |  | — |  |  | 305 |
Other long-term assets |  | 555 |  |  | — |  |  | 136 |  |  | — |  |  | 691 |
Accounts payable |  | — |  |  | — |  |  | — |  |  | (667) |  |  | (667) |
Accrued liabilities |  | — |  |  | — |  |  | — |  |  | (2,346) |  |  | (2,346) |
Other long-term liabilities (1) |  | — |  |  | (52) |  |  | (108) |  |  | (1,762) |  |  | (1,922) |
Long-term debt (2) |  | — |  |  | — |  |  | — |  |  | (21,453) |  |  | (21,453) |
|  | $ | 2,929 |  |  | $ | 253 |  |  | $ | 28 |  |  | $ | (26,228) |  |  | $ | (23,018) |
(1)Includes $1,584 million of lease liabilities (December 31, 2020 – $1,690 million) and $48 million of deferred purchase consideration payable over the next two years (December 31, 2020 – $72 million). (2)Includes the current portion of long-term debt. The fair values of the Company’s investments, recurring other long-term assets (liabilities) and fixed rate long-term debt are outlined below:
|  |  | 2021
|  | Carrying amount |  | Fair value
Asset (liability) (1) (2) |  |  |  |  | Level 1 |  | Level 2 |  | Level 3 (4)
Investments (3) |  |  | $ | 309 |  |  | $ | 309 |  |  | $ | — |  |  | $ | — |
Other long-term assets |  |  | $ | 140 |  |  | $ | — |  |  | $ | 140 |  |  | $ | — |
Other long-term liabilities |  |  | $ | (133) |  |  | $ | — |  |  | $ | (85) |  |  | $ | (48) |
Fixed rate long-term debt (6) (7) |  |  | $ | (13,554) |  |  | $ | (15,420) |  |  | $ | — |  |  | $ | — |
|  |  | 2020
|  | Carrying amount |  | Fair value
Asset (liability) (1) (2) |  |  |  |  | Level 1 |  | Level 2 |  | Level 3 (4) (5)
Investments (3) |  |  | $ | 305 |  |  | $ | 305 |  |  | $ | — |  |  | $ | — |
Other long-term assets |  |  | $ | 691 |  |  | $ | — |  |  | $ | 136 |  |  | $ | 555 |
Other long-term liabilities |  |  | $ | (232) |  |  | $ | — |  |  | $ | (160) |  |  | $ | (72) |
Fixed rate long-term debt (6) (7) |  |  | $ | (14,254) |  |  | $ | (16,598) |  |  | $ | — |  |  | $ | — |
(1)Excludes financial assets and liabilities where the carrying amount approximates fair value due to the short-term nature of the asset or liability (cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, and purchase consideration payable). (2)There were no transfers between Level 1, 2 and 3 financial instruments. (3)The fair values of the investments are based on quoted market prices. (4)The fair value of the deferred purchase consideration included in other long-term liabilities is based on the present value of future cash payments. (5)The fair value of NWRP subordinated debt was based on the present value of future cash receipts. (6)The fair value of fixed rate long-term debt has been determined based on quoted market prices. (7)Includes the current portion of fixed rate long-term debt.
Schedule of financial liabilities | The carrying amounts of the Company’s financial instruments by category were as follows:
|  | 2021
Asset (liability) |  | Financial assets at amortized cost |  | Fair value through profit or loss |  | Derivatives used for hedging |  | Financial liabilities at amortized cost |  | Total
Cash and cash equivalents |  | $ | 744 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 744 |
Accounts receivable |  | 3,111 |  |  | — |  |  | — |  |  | — |  |  | 3,111 |
Investments |  | — |  |  | 309 |  |  | — |  |  | — |  |  | 309 |
Other long-term assets |  | — |  |  | — |  |  | 140 |  |  | — |  |  | 140 |
Accounts payable |  | — |  |  | — |  |  | — |  |  | (803) |  |  | (803) |
Accrued liabilities |  | — |  |  | — |  |  | — |  |  | (3,064) |  |  | (3,064) |
Other long-term liabilities (1) |  | — |  |  | (64) |  |  | (21) |  |  | (1,632) |  |  | (1,717) |
Long-term debt (2) |  | — |  |  | — |  |  | — |  |  | (14,694) |  |  | (14,694) |
|  | $ | 3,855 |  |  | $ | 245 |  |  | $ | 119 |  |  | $ | (20,193) |  |  | $ | (15,974) |
|  | 2020
Asset (liability) |  | Financial assets at amortized cost |  | Fair value through profit or loss |  | Derivatives used for hedging |  | Financial liabilities at amortized cost |  | Total
Cash and cash equivalents |  | $ | 184 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 184 |
Accounts receivable |  | 2,190 |  |  | — |  |  | — |  |  | — |  |  | 2,190 |
Investments |  | — |  |  | 305 |  |  | — |  |  | — |  |  | 305 |
Other long-term assets |  | 555 |  |  | — |  |  | 136 |  |  | — |  |  | 691 |
Accounts payable |  | — |  |  | — |  |  | — |  |  | (667) |  |  | (667) |
Accrued liabilities |  | — |  |  | — |  |  | — |  |  | (2,346) |  |  | (2,346) |
Other long-term liabilities (1) |  | — |  |  | (52) |  |  | (108) |  |  | (1,762) |  |  | (1,922) |
Long-term debt (2) |  | — |  |  | — |  |  | — |  |  | (21,453) |  |  | (21,453) |
|  | $ | 2,929 |  |  | $ | 253 |  |  | $ | 28 |  |  | $ | (26,228) |  |  | $ | (23,018) |
(1)Includes $1,584 million of lease liabilities (December 31, 2020 – $1,690 million) and $48 million of deferred purchase consideration payable over the next two years (December 31, 2020 – $72 million). (2)Includes the current portion of long-term debt. The fair values of the Company’s investments, recurring other long-term assets (liabilities) and fixed rate long-term debt are outlined below:
|  |  | 2021
|  | Carrying amount |  | Fair value
Asset (liability) (1) (2) |  |  |  |  | Level 1 |  | Level 2 |  | Level 3 (4)
Investments (3) |  |  | $ | 309 |  |  | $ | 309 |  |  | $ | — |  |  | $ | — |
Other long-term assets |  |  | $ | 140 |  |  | $ | — |  |  | $ | 140 |  |  | $ | — |
Other long-term liabilities |  |  | $ | (133) |  |  | $ | — |  |  | $ | (85) |  |  | $ | (48) |
Fixed rate long-term debt (6) (7) |  |  | $ | (13,554) |  |  | $ | (15,420) |  |  | $ | — |  |  | $ | — |
|  |  | 2020
|  | Carrying amount |  | Fair value
Asset (liability) (1) (2) |  |  |  |  | Level 1 |  | Level 2 |  | Level 3 (4) (5)
Investments (3) |  |  | $ | 305 |  |  | $ | 305 |  |  | $ | — |  |  | $ | — |
Other long-term assets |  |  | $ | 691 |  |  | $ | — |  |  | $ | 136 |  |  | $ | 555 |
Other long-term liabilities |  |  | $ | (232) |  |  | $ | — |  |  | $ | (160) |  |  | $ | (72) |
Fixed rate long-term debt (6) (7) |  |  | $ | (14,254) |  |  | $ | (16,598) |  |  | $ | — |  |  | $ | — |
(1)Excludes financial assets and liabilities where the carrying amount approximates fair value due to the short-term nature of the asset or liability (cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, and purchase consideration payable). (2)There were no transfers between Level 1, 2 and 3 financial instruments. (3)The fair values of the investments are based on quoted market prices. (4)The fair value of the deferred purchase consideration included in other long-term liabilities is based on the present value of future cash payments. (5)The fair value of NWRP subordinated debt was based on the present value of future cash receipts. (6)The fair value of fixed rate long-term debt has been determined based on quoted market prices. (7)Includes the current portion of fixed rate long-term debt.
Schedule of information about financial instruments | The following provides a summary of the carrying amounts of derivative financial instruments held and a reconciliation to the Company’s consolidated balance sheets.
Asset (liability) |  | 2021 |  | 2020
Derivatives held for trading |  |  |  |
Natural gas (1) |  | $ | (41) |  |  | $ | (45) |
Crude oil (1) |  | (10) |  |  | — |
Foreign currency forward contracts |  | (13) |  |  | (7) |
Cash flow hedges |  |  |  |
Foreign currency forward contracts |  | (21) |  |  | (108) |
Cross currency swaps |  | 140 |  |  | 136 |
|  | $ | 55 |  |  | $ | (24) |
Included within: |  |  |  |
Current portion of other long-term assets |  | $ | 5 |  |  | $ | 5 |
Current portion of other long-term liabilities |  | (72) |  |  | (131) |
Other long-term assets |  | 135 |  |  | 131 |
Other long-term liabilities |  | (13) |  |  | (29) |
|  | $ | 55 |  |  | $ | (24) |
(1) Commodity financial instruments acquired from Storm and Painted Pony in 2021 and 2020, respectively. The changes in estimated fair values of derivative financial instruments included in the risk management asset (liability) were recognized in the financial statements as follows:
Asset (liability) |  | 2021 |  | 2020
Balance – beginning of year |  | $ | (24) |  |  | $ | 178 |
Net change in fair value of outstanding derivative financial instruments recognized in: |  |  |  |
Risk management activities (1) |  | (12) |  |  | (32) |
Foreign exchange |  | 82 |  |  | (168) |
Other comprehensive income (loss) |  | 9 |  |  | (2) |
Balance – end of year |  | 55 |  |  | (24) |
Less: current portion |  | (67) |  |  | (126) |
|  | $ | 122 |  |  | $ | 102 |
(1) Includes the fair value movement of commodity financial instruments included in acquisitions (note 7). Net loss (gain) from risk management activities for the years ended December 31, were as follows:
|  | 2021 |  | 2020 |  | 2019
Net realized risk management loss |  | $ | 17 |  |  | $ | 32 |  |  | $ | 64 |
Net unrealized risk management loss (gain) |  | 19 |  |  | (39) |  |  | 13 |
|  | $ | 36 |  |  | $ | (7) |  |  | $ | 77 |
Schedule of derivative financial instruments | At December 31, 2021 the Company had the following cross currency swap contract outstanding:
| Remaining term | Amount | Exchange rate (US$/C$) | Interest rate (US$) | Interest rate (C$)
Cross Currency Swap | Jan 2022 | – | Mar 2038 | US$550 | 1.170 |  | 6.25 | % | 5.76 | %
Disclosure of financial instrument sensitivities | The following table summarizes the annualized sensitivities of the Company’s 2021 net earnings and other comprehensive income to changes in the fair value of financial instruments outstanding as at December 31, 2021, resulting from changes in the specified variable, with all other variables held constant. These sensitivities are prepared on a different basis than those sensitivities disclosed in the Company’s other continuous disclosure documents, are limited to the impact of changes in a specified variable applied to financial instruments only and do not represent the impact of a change in the variable on the operating results of the Company taken as a whole. Further, these sensitivities are theoretical, as changes in one variable may contribute to changes in another variable, which may magnify or counteract the sensitivities. In addition, changes in fair value generally cannot be extrapolated because the relationship of a change in an assumption to the change in fair value may not be linear.
| 2021 (1) | 2020 (1)
| Increase (decrease) to net earnings | Increase (decrease) to other comprehensive income | Increase (decrease) to net earnings | Increase (decrease) to other comprehensive income
Interest rate risk |  |  |  |
Increase interest rate 1% | $ | (13) |  | $ | (29) |  | $ | (53) |  | $ | (17) |
Decrease interest rate 1% | $ | 13 |  | $ | 39 |  | $ | 53 |  | $ | 20 |
Foreign currency exchange rate risk |  |  |  |
Weakening of the Canadian dollar by US$0.01 | $ | (116) |  | $ | — |  | $ | (126) |  | $ | — |
Strengthening of the Canadian dollar by US$0.01 | $ | 114 |  | $ | — |  | $ | 123 |  | $ | — |
(1) Based on the Company’s contracted natural gas and crude oil financial instruments at December 31, 2021 and December 31, 2020, a movement of $0.10/MMBtu, $0.10/Mcf or $1.00/bbl would not have a significant impact on net earnings or other comprehensive income.
Schedule of maturity dates for financial liabilities | Scheduled debt repayments are as follows:
Year | Repayment
2022 | $ | 1,000 |
2023 | $ | 2,906 |
2024 | $ | 1,133 |
2025 | $ | 1,518 |
2026 | $ | 600 |
Thereafter | $ | 7,624 |
The maturity dates of the Company’s financial liabilities were as follows:
|  | Less than 1 year |  | 1 to less than 2 years |  | 2 to less than 5 years |  | Thereafter
Accounts payable |  | $ | 803 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Accrued liabilities |  | $ | 3,064 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Long-term debt (1) |  | $ | 1,000 |  |  | $ | 2,906 |  |  | $ | 3,251 |  |  | $ | 7,624 |
Other long-term liabilities (2) |  | $ | 282 |  |  | $ | 181 |  |  | $ | 430 |  |  | $ | 824 |
Interest and other financing expense (3) |  | $ | 650 |  |  | $ | 583 |  |  | $ | 1,503 |  |  | $ | 3,971 |
(1)Long-term debt represents principal repayments only and does not reflect interest, original issue discounts and premiums or transaction costs. (2)Lease payments included within other long-term liabilities reflect principal payments only and are as follows; less than one year, $185 million; one to less than two years, $149 million; two to less than five years, $426 million; and thereafter, $824 million. (3)Includes interest and other financing expense on long-term debt and other long-term liabilities. Payments were estimated based upon applicable interest and foreign exchange rates at December 31, 2021.

X
- Definition Financial Instruments [Abstract] + References No definition available. + Details
Name: | cnq_FinancialInstrumentsAbstract
Namespace Prefix: | cnq_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of detailed information about financial instruments. [Refer: Financial instruments, class [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2021-01-01 -Paragraph 31 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2021-01-01 -Paragraph 7 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard -URIDate 2021-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2021-01-01 -Paragraph 35K -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35K&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of detailed information about hedging instruments. [Refer: Hedging instruments [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2021-01-01 -Paragraph 24A -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24A&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutHedgingInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of financial assets. [Refer: Financial assets] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2021-01-01 -Paragraph 7 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfFinancialAssetsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of financial liabilities. [Refer: Financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2021-01-01 -Paragraph 7 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2021-01-01 -Paragraph 39 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39_a&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the sensitivity analysis for types of market risk to which the entity is exposed, showing how profit or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date. [Refer: Market risk [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2021-01-01 -Paragraph 40 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_40_a&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration